Epidemiologic Study to Assess the IGRA Positivity in Populations With a High TB Burden

CompletedOBSERVATIONAL
Enrollment

7,203

Participants

Timeline

Start Date

December 20, 2021

Primary Completion Date

September 11, 2023

Study Completion Date

August 16, 2024

Conditions
Tuberculosis, Pulmonary
Trial Locations (36)

1112

Investigational Site, Quezon City

1212

Investigational Site, Dhaka

1229

Investigational Site, Makati City

1401

Investigational Site, Germiston

1552

Investigational Site, Mandaluyong

1818

Investigational Site, Soweto

1935

Investigational Site, Three Rivers

3935

Investigational Site, Mtubatuba

3943

Investigational Site, Maputo

4091

Investigational Site, Durban

4114

Investigational Site, Dasmariñas

5000

Investigational Site, Iloilo City

8301

Investigational Site, Kimberley

9301

Investigational Site, Bloemfontein

10005

Investigational Site, Entebbe

10101

Investigational Site, Emmasdale

Investigational Site, Lusaka

13230

Investigational Site, Persabahan

13510

Investigational Site, Bakti

15313

Investigational Site, Lima

15324

Investigational Site, Comas

40100

Investigational Site, Kisumu

45363

Investigational Site, Bandung

72052

Investigational Site, Mulago

100000

Investigational Site, Hà Nội

240262

Investigational Site, Ndola

411018

Investigational Site, Pune

700000

Investigational Site, Ho Chi Minh City

90035-903

Investigational Site, Porto Alegre

21040-360

Investigational Site, Rio de Janeiro

0000

Investigational Site, Kinshasa

Investigational Site, Mombasa

00100

Investigational Site, Nairobi

01929

Investigational Site, Manica

0152

Investigational Site, Soshanguve

00220

Investigational Site, Banjul

All Listed Sponsors
lead

Gates Medical Research Institute

OTHER